Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Extended HPV Vaccination Schemes in Mexico
NCT01717118Phase 4Completed
- Sponsor
- Instituto Nacional de Salud Pública
- Start
- Nov 2009
- Primary completion
- Feb 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of qHPV vaccine, human papillomavirus type 16 L1 capsid protein antigen in human papillomavirus infection, sponsored by Instituto Nacional de Salud Pública. Started Nov 2009; status: completed.
02
Drugs
qHPV vaccinehuman papillomavirus type 16 L1 capsid protein antigen
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT01717118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01717118.